Correlation Analysis between Helicobacter pylori Infection Status and Tumor Clinical Pathology as Well as Prognosis of Gastric Cancer Patients
Background: We aimed to investigate the correlation between Helicobacter pylori infection and the development and prognosis of gastric cancer.
Methods: Retrospective analysis was used to collect 120 paraffin-embedded specimens and 42 paracancerous specimens of gastric cancer patients archived in Department of Pathology, Weihaiwei People’s Hospital from 2010-2012. All patients with gastric cancer were followed for 5 years. Real-time fluorescent quantitative PCR was used to detect the relative H. pylori infection in gastric cancer tissues and paracancerous tissues. The relationship between clinicopathological parameters and H. pylori relative infection was analyzed. Kaplan-Meier was used for survival analysis.
Results: The relative amount of H. pylori infection in gastric cancer tissues was significantly higher than that in paracancerous normal tissues (P<0.001). The relative H. pylori infection was related to tumor size, lymph node metastasis, clinical stage, and depth of invasion (P<0.05). The 1-, 3-, and 5-year survival rates of gastric cancer patients were negatively correlated with the relative H. pylori infection. The relative H. pylori infection, age, tumor size, lymph node metastasis, distant metastasis, clinical stage and depth of invasion were positively correlated with the prognosis of patients with gastric cancer.
Conclusion: The relative H. pylori infection and clinical stage of patients could increase the risk of death in gastric cancer patients. H. pylori is one of the independent risk factors for the progression and prognosis of gastric cancer. It is also an index to evaluate the development process and prognosis of gastric cancer.
2. Ferro A, Peleteiro B, Malvezzi M et al (2014). Worldwide trends in gastric can-cer mortality (1980-2011), with predic-tions to 2015, and incidence by subtype. Eur J Cancer, 50: 1330-1344.
3. Gonzalez CA, Agudo A (2012). Carcino-genesis, prevention and early detection of gastric cancer: where we are and where we should go. Int J Cancer, 130: 745-753.
4. Paoletti X, Oba K, Burzykowski T et al (2010). Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA, 303: 1729-1737.
5. Torre LA, Bray F, Siegel RL, Ferlay J, Lor-tet-Tieulent J, Jemal A (2015). Global can-cer statistics, 2012. CA Cancer J Clin, 65: 87-108.
6. Peek RM, Jr., Blaser MJ (2002). Helicobacter pylori and gastrointestinal tract adenocar-cinomas. Nat Rev Cancer, 2: 28-37.
7. Rain JC, Selig L, Reuse HD et al (2001). Er-ratum: The protein–protein interaction map of Helicobacter pylori. Nature, 409: 211-215.
8. Uemura N (2003). Helicobacter pylori infection and the development of gastric cancer. N Nihon Rinsho, 61:25-29.
9. Talley NJ, Vakil N, Ballard ED 2nd, Fen-nerty MB (1999). Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl J Med, 341(15):1106-11.
10. Group TE (1993). An international associa-tion between Helicobacter pylori infection and gastric cancer. Lancet, 341:1359-1362.
11. Polk DB, Peek RM, Jr. (2010). Helicobacter py-lori: gastric cancer and beyond. Nat Rev Cancer, 10: 403-414.
12. Odenbreit S, Püls J, Sedlmaier B, Gerland E, Fischer W, Haas R (2000). Translocation of Helicobacter pylori CagA into Gastric Epithelial Cells by Type IV Secretion. Sci-ence, 287: 1497-1500.
13. Edge SB, Compton CC (2010). The Ameri-can Joint Committee on Cancer: the 7th edition of the AJCC cancer staging man-ual and the future of TNM. Ann Surg On-col, 17: 1471-1474.
14. Vaira D, Malfertheiner P, Megraud F et al (2000). Noninvasive antigen-based assay for assessing Helicobacter pylori eradication: a European multicenter study. The Euro-pean Helicobacter pylori HpSA Study Group. Am J Gastroenterol, 95: 925-929.
15. Poplawski T, Chojnacki C, Czubatka A, Klupinska G, Chojnacki J, Blasiak J (2013). Helicobacter pylori infection and an-tioxidants can modulate the genotoxic ef-fects of heterocyclic amines in gastric mucosa cells. Mol Biol Rep, 40: 5205-5212.
16. Park JS, Yeom JS, Seo JH et al (2015). Im-munohistochemical Expressions of MUC2, MUC5AC, and MUC6 in Nor-mal, Helicobacter pylori Infected and Meta-plastic Gastric Mucosa of Children and Adolescents. Helicobacter, 20: 260-268.
17. Guindi M (1999). Role of Helicobacter pylori in the pathogenesis of gastric carcinoma and progression of lymphoid nodules to lymphoma. Can J Gastroenterol, 13: 224-227.
18. Parsonnet J, Friedman GD, Vandersteen DP et al (1991). Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med, 325: 1127-1131.
19. Uemura N (2003). [H. pylori infection and the development of gastric cancer in Ja-pan]. Nihon Rinsho, 61: 25-29.
20. Peek RM, Jr., Blaser MJ (2002). Helicobacter pylori and gastrointestinal tract adenocar-cinomas. Nat Rev Cancer, 2: 28-37.
21. Wroblewski LE, Peek RM, Jr., Wilson KT (2010). Helicobacter pylori and gastric can-cer: factors that modulate disease risk. Clin Microbiol Rev, 23: 713-739.
22. Meimarakis G, Winter H, Assmann I et al (2006). Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study. Lancet On-col, 7: 211-222.
23. Qiu HB, Zhang L Y, Keshari R P, et al (2010). Relationship between H.Pylori in-fection and clinicopathological features and prognosis of gastric cancer. BMC Cancer, 10: 374.
24. Choi IK, Sung HJ, Lee JH, Kim JS, Seo JH (2012). The relationship between Helico-bacter pylori infection and the effects of chemotherapy in patients with advanced or metastatic gastric cancer. Cancer Chemother Pharmacol, 70: 555-558.
25. Wang F, Sun G, Zou Y, Zhong F, Ma T, Li X (2013). Protective role of Helicobacter py-lori infection in prognosis of gastric can-cer: evidence from 2,454 patients with gastric cancer. PLoS One, 8: e62440.
26. Seo JY, Jin EH, Yoon H, et al (2015). Char-acteristics and prognosis of gastric cancer according to Helicobacter pylori. J Clin Oncol, 33 (3_suppl): 14-14.
27. Tsai KF, Liou JM, Chen MJ et al (2017). Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer. PLoS One, 12: e0170942.
|Issue||Vol 47 No 10 (2018)|
|Gastric cancer, Helicobacter pylori, Clinical pathology, Prognosis, Correlation analysis|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|